这篇文章不错，转发给_老虎社区_美港股上老虎

2024-12-23

这篇文章不错，转发给大家看看

Stock Track | Bionano Genomics Soars 7.64% Pre-Market on Promising Optical Genome Mapping Study Results<blockquote>股票跟踪 | Bionano Genomics 因光学基因组图谱研究结果令人鼓舞，盘前股价飙升 7.64%</blockquote>

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":384789396406384,"tweetId":"384789396406384","gmtCreate":1734962792818,"gmtModify":1734962794641,"author":{"id":3521442285147631,"idStr":"3521442285147631","authorId":3521442285147631,"authorIdStr":"3521442285147631","name":"SebuOba","avatar":"https://static.tigerbbs.com/b7883780849644650e2c9e643a0f9d6d","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"hat":"https://static.tigerbbs.com/95a0ce7a7fe8e0518b38aeef5c80667c","crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":4,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><p>这篇文章不错，转发给大家看看</p></body></html>","htmlText":"<html><head></head><body><p>这篇文章不错，转发给大家看看</p></body></html>","text":"这篇文章不错，转发给大家看看","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/384789396406384","repostId":1107013571,"repostType":2,"repost":{"id":"1107013571","kind":"news","weMediaInfo":{"introduction":"Track stock‘s movements and relevant news","home_visible":1,"media_name":"Stock Track","id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"pubTimestamp":1734961705,"share":"https://www.laohu8.com/m/news/1107013571?lang=zh_CN&edition=full","pubTime":"2024-12-23 21:48","market":"hk","language":"en","title":"Stock Track | Bionano Genomics Soars 7.64% Pre-Market on Promising Optical Genome Mapping Study Results<blockquote>股票跟踪 | Bionano Genomics 因光学基因组图谱研究结果令人鼓舞，盘前股价飙升 7.64%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1107013571","media":"Stock Track","summary":"Bionano Genomics  stock surged 7.64% in the pre-market session on Monday.The rally comes after the company announced positive results from a study at Johns Hopkins University School of Medicine, showing that its Optical Genome Mapping  technology outperformed multiple cytogenetic assays in the analysis of bone and soft tissue tumors.- OGM detected 100% of variants found by standard techniques like karyotyping and FISH. - OGM was more sensitive, detecting diagnostic variants missed by karyotyping","content":"<p>Bionano Genomics (BNGO) stock surged 7.64% in the pre-market session on Monday.</p><p><blockquote>Bionano Genomics (BNGO) 股价在周一盘前交易中飙升 7.64%。</blockquote></p><p>  The rally comes after the company announced positive results from a study at Johns Hopkins University School of Medicine, showing that its Optical Genome Mapping (OGM) technology outperformed multiple cytogenetic assays in the analysis of bone and soft tissue tumors.  Key findings included: - OGM detected 100% of variants found by standard techniques like karyotyping and FISH - OGM was more sensitive, detecting diagnostic variants missed by karyotyping in 74% of failed/negative cases - Combined with next-generation sequencing, OGM found diagnostic variants in ~98% of cases, substantially higher than standard methods The researchers highlighted OGM's potential to qualify more patients for targeted therapies or clinical trials based on the additional variants detected. </p><p><blockquote>此前，该公司宣布了约翰霍普金斯大学医学院的一项研究的积极结果，表明其光学基因组作图 (OGM) 技术在分析骨和软组织肿瘤方面优于多种细胞遗传学检测。主要发现包括： - OGM 检测到了核型分析和 FISH 等标准技术发现的 100% 的变异 - OGM 更敏感，在 74% 的失败/阴性病例中检测到了核型分析遗漏的诊断变异 - 结合下一代测序，OGM 在约 98% 的病例中发现了诊断变异，大大高于标准方法 研究人员强调了 OGM 的潜力，可以根据检测到的其他变异使更多患者有资格接受靶向治疗或临床试验。</blockquote></p><p>  The positive study results suggest increasing adoption potential for Bionano's OGM technology beyond blood cancers into solid tumor analysis as well.</p><p><blockquote>积极的研究结果表明，除了血癌之外，Bionano的转基因技术在实体瘤分析中的应用潜力越来越大。</blockquote></p><p></p>","source":"ai_movement_en","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Bionano Genomics Soars 7.64% Pre-Market on Promising Optical Genome Mapping Study Results<blockquote>股票跟踪 | Bionano Genomics 因光学基因组图谱研究结果令人鼓舞，盘前股价飙升 7.64%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Bionano Genomics Soars 7.64% Pre-Market on Promising Optical Genome Mapping Study Results<blockquote>股票跟踪 | Bionano Genomics 因光学基因组图谱研究结果令人鼓舞，盘前股价飙升 7.64%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2024-12-23 21:48</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Bionano Genomics (BNGO) stock surged 7.64% in the pre-market session on Monday.</p><p><blockquote>Bionano Genomics (BNGO) 股价在周一盘前交易中飙升 7.64%。</blockquote></p><p>  The rally comes after the company announced positive results from a study at Johns Hopkins University School of Medicine, showing that its Optical Genome Mapping (OGM) technology outperformed multiple cytogenetic assays in the analysis of bone and soft tissue tumors.  Key findings included: - OGM detected 100% of variants found by standard techniques like karyotyping and FISH - OGM was more sensitive, detecting diagnostic variants missed by karyotyping in 74% of failed/negative cases - Combined with next-generation sequencing, OGM found diagnostic variants in ~98% of cases, substantially higher than standard methods The researchers highlighted OGM's potential to qualify more patients for targeted therapies or clinical trials based on the additional variants detected. </p><p><blockquote>此前，该公司宣布了约翰霍普金斯大学医学院的一项研究的积极结果，表明其光学基因组作图 (OGM) 技术在分析骨和软组织肿瘤方面优于多种细胞遗传学检测。主要发现包括： - OGM 检测到了核型分析和 FISH 等标准技术发现的 100% 的变异 - OGM 更敏感，在 74% 的失败/阴性病例中检测到了核型分析遗漏的诊断变异 - 结合下一代测序，OGM 在约 98% 的病例中发现了诊断变异，大大高于标准方法 研究人员强调了 OGM 的潜力，可以根据检测到的其他变异使更多患者有资格接受靶向治疗或临床试验。</blockquote></p><p>  The positive study results suggest increasing adoption potential for Bionano's OGM technology beyond blood cancers into solid tumor analysis as well.</p><p><blockquote>积极的研究结果表明，除了血癌之外，Bionano的转基因技术在实体瘤分析中的应用潜力越来越大。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNGO":"Bionano Genomics"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1107013571","content_text":"Bionano Genomics (BNGO) stock surged 7.64% in the pre-market session on Monday.\nThe rally comes after the company announced positive results from a study at Johns Hopkins University School of Medicine, showing that its Optical Genome Mapping (OGM) technology outperformed multiple cytogenetic assays in the analysis of bone and soft tissue tumors. \nKey findings included:\n- OGM detected 100% of variants found by standard techniques like karyotyping and FISH\n- OGM was more sensitive, detecting diagnostic variants missed by karyotyping in 74% of failed/negative cases\n- Combined with next-generation sequencing, OGM found diagnostic variants in ~98% of cases, substantially higher than standard methods\nThe researchers highlighted OGM's potential to qualify more patients for targeted therapies or clinical trials based on the additional variants detected.\n\nThe positive study results suggest increasing adoption potential for Bionano's OGM technology beyond blood cancers into solid tumor analysis as well.","news_type":1,"symbols_score_info":{"BNGO":1}},"isVote":1,"tweetType":1,"viewCount":1738,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":27,"subscribersOnly":false,"subscribersOnlyAccessible":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/384789396406384"}